Albireo Pharma Probability of Future Stock Price Finishing Over 48.57

ALBODelisted Stock  USD 44.15  0.75  1.67%   
Albireo Pharma's future price is the expected price of Albireo Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Albireo Pharma performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
  
Please specify Albireo Pharma's target price for which you would like Albireo Pharma odds to be computed.

Albireo Pharma Target Price Odds to finish over 48.57

The tendency of Albireo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 48.57  or more in 90 days
 44.15 90 days 48.57 
about 10.3
Based on a normal probability distribution, the odds of Albireo Pharma to move over $ 48.57  or more in 90 days from now is about 10.3 (This Albireo Pharma probability density function shows the probability of Albireo Stock to fall within a particular range of prices over 90 days) . Probability of Albireo Pharma price to stay between its current price of $ 44.15  and $ 48.57  at the end of the 90-day period is about 8.64 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.43 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Albireo Pharma will likely underperform. Moreover Albireo Pharma has an alpha of 1.3573, implying that it can generate a 1.36 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Albireo Pharma Price Density   
       Price  

Predictive Modules for Albireo Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Albireo Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
44.1544.1544.15
Details
Intrinsic
Valuation
LowRealHigh
32.1432.1448.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Albireo Pharma.

Albireo Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Albireo Pharma is not an exception. The market had few large corrections towards the Albireo Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Albireo Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Albireo Pharma within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
1.36
β
Beta against NYSE Composite2.43
σ
Overall volatility
11.49
Ir
Information ratio 0.12

Albireo Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Albireo Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Albireo Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Albireo Pharma is not yet fully synchronised with the market data
Albireo Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 40.58 M. Net Loss for the year was (34.03 M) with profit before overhead, payroll, taxes, and interest of 39.22 M.
Albireo Pharma currently holds about 180.97 M in cash with (107.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.23.
Over 96.0% of the company shares are held by institutions such as insurance companies

Albireo Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Albireo Stock often depends not only on the future outlook of the current and potential Albireo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Albireo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding19.2 M
Cash And Short Term Investments248.1 M

Albireo Pharma Technical Analysis

Albireo Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Albireo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Albireo Pharma. In general, you should focus on analyzing Albireo Stock price patterns and their correlations with different microeconomic environments and drivers.

Albireo Pharma Predictive Forecast Models

Albireo Pharma's time-series forecasting models is one of many Albireo Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Albireo Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Albireo Pharma

Checking the ongoing alerts about Albireo Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Albireo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Albireo Pharma is not yet fully synchronised with the market data
Albireo Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 40.58 M. Net Loss for the year was (34.03 M) with profit before overhead, payroll, taxes, and interest of 39.22 M.
Albireo Pharma currently holds about 180.97 M in cash with (107.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.23.
Over 96.0% of the company shares are held by institutions such as insurance companies
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios